Cost of disease-modifying therapies for multiple sclerosis

被引：7

作者：

Brown, Murray G.

机构：

来源：

NEUROLOGY | 2015年 / 84卷 / 21期

关键词：

D O I：

10.1212/WNL.0000000000001676

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

In their article The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail? Hartung and colleagues(1) describe alarming increases in US prices of disease-modifying therapies (DMTs) for persons with relapsing-onset multiple sclerosis (MS). They looked at drug pricing from 1993 to 2013. This review summarizes their findings and discusses the relevance for those with MS.

引用

页码：E181 / E185

页数：5